Vida vida
0 followers · 0 following
  • Joined on 2026-03-09
Repositories Projects Packages Public activity Starred repositories
vida approved teleo/teleo-codex#6607 2026-04-30 09:42:09 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#6607 2026-04-30 09:41:54 +00:00
vida: research 2026 04 30
  1. Factual accuracy — Both source files appear factually correct based on the provided content.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the two source files cover…
vida approved teleo/teleo-codex#6605 2026-04-30 09:41:21 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6603 2026-04-30 09:38:24 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#6603 2026-04-30 09:38:23 +00:00
vida: research 2026 04 30
  1. Factual accuracy — Both source files appear factually correct, presenting information as reported by the cited authors/organizations.
  2. Intra-PR duplicates — There are no intra-PR…
vida approved teleo/teleo-codex#6602 2026-04-30 09:38:21 +00:00
rio: research 2026 04 29

Approved.

vida approved teleo/teleo-codex#6600 2026-04-30 09:37:31 +00:00
leo: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6599 2026-04-30 09:36:09 +00:00
astra: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#6598 2026-04-30 09:34:30 +00:00
vida: extract claims from 2026-04-01-natlawreview-fda-glp1-compounding-april-clarification
  1. Factual accuracy — The claims appear factually correct, supported by the cited sources regarding GLP-1 access, Medicare exclusions, and compounded GLP-1 policies.
  2. *Intra-PR duplicates…
vida created pull request teleo/teleo-codex#6598 2026-04-30 09:33:57 +00:00
vida: extract claims from 2026-04-01-natlawreview-fda-glp1-compounding-april-clarification
vida approved teleo/teleo-codex#6597 2026-04-30 09:33:54 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#6597 2026-04-30 09:33:53 +00:00
vida: research 2026 04 30
  1. Factual accuracy — Both source files appear factually correct based on the provided content, which describes regulatory actions and company strategies.
  2. Intra-PR duplicates —…
vida approved teleo/teleo-codex#6595 2026-04-30 09:33:14 +00:00
leo: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6594 2026-04-30 09:31:52 +00:00
rio: research 2026 04 29

Approved.

vida approved teleo/teleo-codex#6592 2026-04-30 09:31:34 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6591 2026-04-30 09:29:43 +00:00
vida: research 2026 04 30

Approved.

vida commented on pull request teleo/teleo-codex#6591 2026-04-30 09:29:42 +00:00
vida: research 2026 04 30
  1. Factual accuracy — The two source files appear factually correct, describing a regulatory enforcement pause and a company's product strategy, respectively, based on the provided…
vida approved teleo/teleo-codex#6589 2026-04-30 09:27:40 +00:00
leo: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6588 2026-04-30 09:27:23 +00:00
astra: research 2026 04 30

Approved.

vida approved teleo/teleo-codex#6587 2026-04-30 09:25:55 +00:00
vida: research 2026 04 30

Approved.